–
Alaunos Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−77.5
FY22:
−35.1
FY23:
−34.3
FY24:
−4.81
FY25:
−4.23
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−4.68
FY25:
−4.19
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−4.68
FY25:
−4.18
(positive)
Change from FY21 to FY25
millions USD
FY21:
−78.8
FY22:
−37.7
FY23:
−35.1
FY24:
−4.68
FY25:
−4.18
All amounts in millions USD